Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Jean-Paul Janssens, Ligue Pulmonaire Genevoise
ClinicalTrials.gov Identifier:
NCT01608685
First received: July 5, 2011
Last updated: May 30, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):